Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
EyePoint's Phase 3 program for DURAVYU is shaping up as a meaningful durability and safety story. With three consecutive positive DSMC recommendations, a seasoned ophthalmology commercial chief onboard, and cash runway into Q4 2027, the risk/reward favors a long trade. Entry $14.00, target $20.00, stop $10.00; horizon 180 trading days.
VXUS offers immediate diversification across roughly 8,700+ non-U.S. stocks, a 2.5% distribution yield, and a large, liquid market cap of about $163B. Technicals show recent bullish momentum and average daily volume near 4.6M shares. This trade idea outlines a long trade with defined entry, stop and target for a 180-trading-day time horizon designe…
Algonquin Power & Utilities (AQN) looks set for a mid-term swing as the company’s transition to a regulated-only profile stabilizes cash flow and supports a 4.6% yield. Market cap of $4.55B, a PB near 1.02 and recent technicals near support make a disciplined long with a clear stop and a target at the 52-week high a pragmatic trade.
Boeing is positioned to convert certification and backlog into cash flow over the next 12-18 months. The FAA's 737 MAX 7 approval and fresh defense awards create a near-term catalyst mix, while improving production and strong travel demand underpin a steady revenue base. Valuation is rich on trailing multiples, but the risk/reward favors a tactical…
Palantir delivered a blowout Q2 (93% revenue growth) and guidance lift, and the stock is re-rating as investors rotate into software from chips. The business combines sticky government contracts with accelerating commercial AI wins — a combination that supports a premium multiple. This trade targets continued multiple expansion into $200+ territory…
TAT Technologies (TATT) looks to be stabilizing after a rocky first quarter. Solid Q2 2025 results, a $523M market cap, and improving MRO demand underpin our bullish trade idea. We outline an actionable entry at $39.50, a $34.50 stop, and a $55.00 target over a mid-term (45 trading days) horizon, with clear risk triggers and what would change our v…
Iran and Oman are reportedly close to finalizing an agreement on a new shipping route through the Strait of Hormuz, but Tehran says reopening the waterway will depend on broader conditions, including concessions from Washington. U.S. officials say a deal could trigger the lifting of a blockade on Iranian ports, while the United Arab Emirates report…
<p>Roivant (ROIV) is trading within striking distance of its 52-week high while sitting on a balance sheet that looks more like a strategic toolkit than a simple war chest. The company reported roughly $4.4B in cash and effectively no debt, giving management real optionality to fund late-stage programs, pursue tuck-in acquisitions, or return capita…
Idexx (IDXX) is a high-quality diagnostics business with recurring revenue, industry-leading margins and accelerating diagnostic frequency. Recent results and raised guidance support continued top-line momentum. The stock trades at a premium, but fundamentals and cash generation make a disciplined long trade attractive over a 180 trading-day horizo…
B2Gold's fire at the Goose crushing circuit is a definable, contained hit to Q2 output but does not change the company's cash-generation profile or strategic progress. Use a disciplined, mid-term long trade that leans on de-risking from the Fingold sale, robust production last year and heavy intraday flows that can fuel a continuation move.
B2Gold just turned a string of operational and corporate catalysts into a clear trading opportunity. Fekola's steady output, a $325M divestiture, and resilient quarterly metrics have combined with heavy volume and bullish momentum to create an actionable mid-term long setup. Entry at $5.03, target $6.28, stop $4.00 — mid-term (45 trading days) plan…
Altria (MO) corrected sharply after a Q2 miss and volume headwinds, but the balance sheet, $9.1B in free cash flow, a ~6.2% yield and single-digit FCF valuation make this a tactical buy for a long-term trade horizon. This idea lays out entry, stop and target with catalysts and a balanced risk view.
Microsoft is trading near $500 after an extended run, but the core business - cloud, Office, LinkedIn and a growing AI platform - still generates predictable cash flow and profitable growth. At a market cap north of $3.7 trillion and free cash flow near $67B, Microsoft remains a buy-and-hold anchor with room to compound over the next 180 trading da…
Microsoft is benefiting from a clear rotation into software amid the 2026 AI wave. Fundamentals remain solid - $3.80T market cap, $66.99B free cash flow, and double-digit returns on equity - and technicals show strong momentum. This is a tactical long trade to capture the next leg higher, with a defined stop and target to manage the duration mismat…
Sterling Infrastructure (STRL) is a leader in building large-scale electrical and site systems for AI data centers, e-commerce warehouses and traditional transportation projects. The company is trading well below its highs after a sector-wide correction, but fundamentals remain strong: an e-infrastructure backlog above $5.1B, projected full-year re…
Wingstop has seen its share price collapse from cycle highs, but the underlying business - an asset-light, franchise-led model with strong FCF and a massive committed unit pipeline - still points to material upside. This trade idea lays out an actionable long with entry, stop and targets across a 45-to-180 trading-day horizon, plus catalysts and ba…
Allstate has completed a dramatic operational recovery: underwriting performance has improved, catastrophe losses are down, and investment yields are benefiting from a higher-rate environment. At $267.06 the stock trades cheaply on trailing multiples, but much of the easy upside from the turnaround is already priced in. This trade idea favors a dis…
Bitcoin traded just under $65,000 amid scrutiny over a recent vulnerability in BTCPay Server that allowed attackers to seize credentials for Lightning Network nodes and concerns about a possible BIP-110 chain split that could enable replay attacks. Market moves were modest as operators race to patch systems and holders weigh the risk of a contentio…
Arm is transitioning from pure-play IP licensing toward a broader role powering agentic AI workloads through CPUs and platform-level offerings. Strong fiscal Q1 results, early AGI CPU demand, and a raised server TAM justify a mid-term long. Valuation is rich, so this trade uses defined entry, stop and target levels to manage risk while capturing up…
KeyCorp (KEY) offers a compelling risk-reward now: a ~4.3% yield, a fresh $3.0 billion buyback authorization and free cash flow of $2.18B support shareholder returns, while valuation sits at P/E ~13.5 and P/B ~1.22. We outline a structured long trade for the next 180 trading days with explicit entry, target and stop-loss levels and balanced risk fr…
Federal Agricultural Mortgage Corp (AGM) is trading on a clear fundamental and technical run: trailing EPS of $18.43, a P/E near 12.8, and a $1.60 quarterly common dividend combine with momentum indicators to argue for a mid-term long. Our trade plan targets a move to $255 with a stop at $224 and a mid-term horizon of 45 trading days.
Northrop Grumman's Q2 cadence and a reported $7.6B Sentinel-related surge sharpen program visibility for Space Systems and strategic deterrence work. With solid free cash flow, healthy returns, and bullish technicals, this trade aims to capture further re-rating over the next 45 trading days while protecting against program or macro setbacks.
Equity Bancshares (EQBK) is a small regional bank trading near $51 with a clear growth-through-acquisition strategy. Recent M&A and steady loan growth support a case for resuming outperformance; valuation is reasonable on a price-to-book of ~1.28 but P/E and EV/EBITDA are elevated. This trade idea outlines a long entry at $50.94 with a $60 target a…
Pacira (PCRX) is a sub-$1.0B market-cap specialty pharma with a recognizable non-opioid franchise (EXPAREL) and complementary assets. New real-world evidence showing large per-case cost savings, paired with improving reimbursement dynamics and a modest valuation (EV/EBITDA ~10.9; market cap ≈ $1.0B), create a tactical long opportunity. Trade plan: …
Pure Cycle Corporation has announced receipt of a notice from Maran Partners Fund nominating five director candidates for the company's 2027 Annual Meeting of Shareholders. The Board's Nominating and Corporate Governance Committee will review these nominees and provide recommendations in the upcoming proxy statement. The company highlights its grow…
